2023 Was a tough 12 months to the biopharma business, with quite a few organizations downsizing and restructuring their workforces to stay afloat. You will find signs of Restoration, as mergers and acquisitions picked up over the pharmaceutical and everyday living sciences industry within the latter A part of 2023 https://sites.google.com/view/bio-sites/blog